| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director, 10% Owner, See Remarks +2 more
11 companies
Rtw Investments, LP is a Director, 10% Owner, See Remarks at RCKT, with reported holdings spanning 11 companies. Recent filings cover 31 purchases and 6 sales. Those positions are worth an estimated $403.1M at current prices.
Our model assigns Rtw Investments, LP a middling insider score of 65/100, based on 7 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +23.5%.
Rtw Investments, LP's largest disclosed position is in STOK as 10% Owner, worth about $101.7M. Net of sales, the recent Form 4 record there shows accumulation of 744,338 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | OBIO Orchestra Biomed Holdings, Inc. | 10% Owner | Sell | 32 | $4.13 | $132.16 | - | -6.8% | - | |
| Apr 20, 2026 | KLRA Kailera Therapeutics, Inc. Common Stock | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +4.9% | - | - | |
| Apr 30, 2025 | OBIO Orchestra Biomed Holdings, Inc. | 10% Owner | Buy | 49,900 | $2.99 | $149,201.00 | +0.6% | +6.4% | +34.3% | |
| Apr 29, 2025 | OBIO Orchestra Biomed Holdings, Inc. | 10% Owner | Buy | 50,000 | $2.53 | $126,500.00 | +0.6% | +34.4% | - | |
| Oct 6, 2022 | RCKT Rocket Pharmaceuticals, Inc. | Director, 10% Owner, See Remarks | Buy | 1,355,932 | $14.75 | $19,999,997.00 | +8.3% | +8.3% | +5.5% | |
| Sep 7, 2022 | MIST Milestone Pharmaceuticals Inc. | 10% Owner | Sell | 1,557,346 | $8.71 | $13,564,483.66 | -26.5% | -48.2% | -66.7% | |
| Sep 7, 2022 | MIST Milestone Pharmaceuticals Inc. | 10% Owner | Buy | 1,557,346 | $8.71 | $13,564,483.66 | +56.5% | -48.2% | -66.7% | |
| Aug 4, 2021 | RNA Avidity Biosciences, Inc. | 10% Owner | Buy | 800,000 | $18.00 | $14,400,000.00 | +20.0% | - | - | |
| May 11, 2021 | RCKT Rocket Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 725,000 | $40.03 | $29,023,490.00 | -4.5% | -20.0% | -81.1% | |
| May 7, 2021 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Sell | 450,000 | $29.98 | $13,491,000.00 | -18.3% | -16.7% | -63.0% |